Jiangsu Apon Medical Technology Co (SZSE:300753) ROCE %: -3.89% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:300753 Jiangsu Apon Medical Technology Co Ltd SZSE:300753
56 GF Score
Price ¥24.41
GF Value ¥17.06
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Jiangsu Apon Medical Technology Co ROCE %?

Jiangsu Apon Medical Technology Co SZSE:300753 -1.89% 56 ROCE % is -3.89% as of Mar. 2026. GuruFocus rates SZSE:300753 with a GF Score™ of 56/100 and a GF Value™ of ¥17.06 (Significantly Overvalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jiangsu Apon Medical Technology Co's annualized ROCE % for the quarter that ended in Mar. 2026 was -3.89%.

Jiangsu Apon Medical Technology Co  (SZSE:300753) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Jiangsu Apon Medical Technology Co ROCE % Related Terms

Jiangsu Apon Medical Technology Co ROCE % Historical Data

* Premium members only.

The historical data trend for Jiangsu Apon Medical Technology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Apon Medical Technology Co ROCE % Chart

Jiangsu Apon Medical Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.20 -11.41 2.32 3.30 -3.16

Jiangsu Apon Medical Technology Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.86 -2.79 4.11 -3.02 -3.89
SZSE:300753
56GF Score
Jiangsu Apon Medical Technology Co Ltd SZSE:300753
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Apon Medical Technology Co ROCE % Calculation

Jiangsu Apon Medical Technology Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-22.826/( ( (863.485 - 125.62) + (859.706 - 153.282) )/ 2 )
=-22.826/( (737.865+706.424)/ 2 )
=-22.826/722.1445
=-3.16 %

Jiangsu Apon Medical Technology Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-27.34/( ( (859.706 - 153.282) + (815.416 - 114.802) )/ 2 )
=-27.34/( ( 706.424 + 700.614 )/ 2 )
=-27.34/703.519
=-3.89 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -3.89% mean?
Jiangsu Apon Medical Technology Co (SZSE:300753) has a ROCE % of -3.89% as of Mar. 2026.
Is Jiangsu Apon Medical Technology Co's ROCE % too high?
Jiangsu Apon Medical Technology Co's current ROCE % is -3.89%. Overall, Jiangsu Apon Medical Technology Co has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Apon Medical Technology Co's ROCE % compare to ISRG and BDX?
Jiangsu Apon Medical Technology Co's ROCE % of -3.89% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.65, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Apon Medical Technology Co's current ROCE % is -3.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Apon Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Apon Medical Technology Co (SZSE:300753) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥17.06, compared to a current price of ¥24.41 — trading 43.1% above its estimated fair value. The current ROCE % is -3.89%. Jiangsu Apon Medical Technology Co's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Jiangsu Apon Medical Technology Co (SZSE:300753), the current ROCE % is -3.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Apon Medical Technology Co (SZSE:300753) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Apon Medical Technology Co stock appears to be overvalued. The current stock price of ¥24.41 is trading 43.1% above its estimated GF Value™ of ¥17.06. GuruFocus considers Jiangsu Apon Medical Technology Co to be Significantly Overvalued.

Key valuation signals for SZSE:300753:

  • ROCE %: -3.89%
  • GF Value™: ¥17.06 vs. price of ¥24.41 (43.1% above fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the SZSE:300753 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangsu Apon Medical Technology Co Business Description

Address East side of Yongtong Avenue, Economic Development Zone, Rudong County, Jiangsu Province, Nantong, CHN, 226400
Jiangsu Apon Medical Technology Co Ltd formerly known as Jiangsu Aipeng Medical Technology Co Ltd is engaged in production, marketing, and integrating the research of surgical appliances. The company's products include open surgical instrument and an endoscopic surgical instrument.
56GF Score

Get the complete analysis for SZSE:300753

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥24.41
Price
¥17.06
GF Value